BioSpace News Archive

Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, announced today that Dominic Clarke, Ph.D. has joined the company as Chief Technical Officer of Cell & Gene Therapy.

Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND), a leading biotech company in fast-acting psychedelics is pleased to announce that it has filed a patent application in the United States Patent and Trademark Office (USPTO), its 4th patent application.

Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15th.

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, reminds stockholders to vote on the proposals listed in the Company’s proxy statement in advance of its upcoming annual meeting.

Prelude Therapeutics Inc. today announced its financial results for the second quarter ended June 30, 2021 and provided an update on recent clinical and development pipeline progress.

Frequency Therapeutics, Inc today announced business updates and financial results for the second quarter ended June 30, 2021.

BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Monday, August 16, 2021, at 8:00 a.m. EDT, to report second quarter 2021 financial results and provide business updates.

Acurx Pharmaceuticals, Inc. announced today that David P. Luci, President & CEO, will present at the Emerging Growth Conference

Noxopharm Pre-clinical Study Confirms Survival Advantage of Combination LuPSMA Therapy in Prostate Cancer

Moleculin Biotech, Inc. today announced its financial results for the quarter ended June 30, 2021.